Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an IL-31 monoclonal antibody for antagonizing signal transduction in spinal cord cells

Use of an IL-31 monoclonal antibody for antagonizing signal transduction in spinal cord cells

US Patent 9631021 · Granted Apr 25, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Remote control2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Methods of selecting, based on polymorphisms, an inflammatory bowel disease subj2025
Jewelry rack2025
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof2024
Optimized anti-TL1A antibodies2022
Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of2022
Methods of treating prurigo nodularis using anti-IL-31RA antibody compositions2022
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof2022
Unified application notification framework2022